To determine the combined effects of NRasG12D activation and EZH2-deficiency, we analyzed the myeloid differentiation pseudotime in all groups at T3 when post-MPN leukemia was observed in G12D/E2-KO mice. This evidence concerns the gene EZH2 and myeloproliferative neoplasm.